This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: The Innovative Contributions of Zhengrong Guo in Epothilone Derivatives
Introduction
Zhengrong Guo, an accomplished inventor based in East Brunswick, NJ, has made significant strides in the field of organic chemistry. His innovative work has led to the development of a valuable patent that enhances the synthesis of commercially important compounds.
Latest Patents
Guo holds a patent for the "Method of preparation of 21-amino epothilone derivatives." This groundbreaking method provides a one-pot conversion of 21-hydroxy epothilones to highly desirable 21-amino epothilones with high yield, marking a notable advancement in the synthesis processes related to these compounds.
Career Highlights
Zhengrong Guo works at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His contributions to the field of pharmaceuticals, particularly in the area of epothilone derivatives, underscore his commitment to innovation in drug development and synthesis.
Collaborations
Throughout his career, Guo has collaborated with notable colleagues, including Denis Favreau and Joydeep Kant. Working alongside such talented individuals has enabled him to further enhance his research and drive forward innovative solutions in pharmaceuticals.
Conclusion
Zhengrong Guo's work exemplifies the impact that dedicated inventors can have on the pharmaceutical industry. His unique method for synthesizing 21-amino epothilones not only reflects his ingenuity but also plays a crucial role in the continued evolution of drug formulation and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile